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Mesangial changes in IgA nephropathy in children
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Mesangial changes in IgA nephropathy in children. The mesangial
changes in 92 renal biopsy specimens from 81 children with IgA
nephropathy were correlated with the clinical and the other renal biopsy
findings. Three types of mesangial changes were identified: mesangial
hypercellularity was predominant compared with the increase in matrix
in 34 biopsy specimens (type A), the degrees of mesangial hypercellu-
larity and matrix increase were similar in 36 (type B) and matrix
increase was predominant in 22 (type C). The interval between the
onset of disease and biopsy was significantly shorter in biopsies with
type A mesangial changes (P < 0.01) and significantly longer in those
with type C (P < 0.01). Serial pathologic observations revealed that
predominant mesangial hypercellularity was almost exclusively seen in
the initial biopsy but predominant matrix increase was usually seen in
the follow—up biopsy. The percentage of glomeruli showing sclerosis
was significantly higher in biopsies with type C mesangial changes (P <
0.05). At the latest follow—up, 58% of the patients showing type A and
57% showing type B lost their proteinuria, whereas only 9% showing
type C lost their proteinuria (P < 0.01). These findings suggest that
predominant mesangial hypercellularity is characteristic of the early
lesion of childhood IgA nephropathy, and progression of disease leads
to gradual decrease of mesangial cellularity and increase of matrix with
sclerosis.
IgA nephropathy was originally described by Berger in 1969
[1] and has been increasingly recognized as a distinct clinico-
pathologic entity. Since the start of a school screening program
by the government in 1974, all Japanese children between the
ages of 6 and 15 years have been screened every year and those
found to have urinary abnormalities are referred for further
investigation. IgA nephropathy has been the most common
primary glomerulonephritis in children attending our renal unit,
and urinary abnormalities were found by the school screening
program in 60% of the children with IgA nephropathy [2—7].
IgA nephropathy is characterized by the diffuse deposition of
IgA and, less frequently and less intensely, IgG and C3 in the
glomerular mesangium. Electron microscopy reveals numerous
electron—dense deposits in the mesangium. On light micros-
copy, the most uniform abnormality is a global or segmental
widening of the glomerular mesangium produced by a variable
combination of hypercellularity and increase in matrix. We
have noted that the early lesion of IgA nephropathy is charac-
terized by a predominance of mesangial hypercellularity com-
pared to increase in matrix, and mesangial cellularity decreases
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and matrix increases with the duration of the disease. The
purpose of this paper is to report pertinent observations made in
renal biopsies from 81 children with IgA nephropathy and
discuss the significance and mechanism of formation of the
mesangial changes.
Methods
All children with IgA nephropathy who had had a renal
biopsy at Kobe University Hospital during the years 1981 to
1986 inclusive were reviewed. The diagnosis was based on the
presence of IgA as the sole or predominant immunoglobulin in
the glomerular mesangium. Patients with systemic diseases,
such as Henoch—SchOnlein syndrome and systemic lupus ery-
thematosus, were excluded.
For purposes of analysis, renal biopsies from patients with
IgA nephropathy were divided into three pathologic types on
the basis of the mesangial changes.
Type A. Mesangial hypercellularity is predominant compared
with increase in matrix (Fig. 1).
Type B. The degrees of mesangial hypercellularity and in-
crease in matrix are similar (Fig. 2).
Type C. Increase in matrix is predominant compared with
mesangial cellularity (Fig. 3).
For the present study all biopsy specimens were re-examined
in a random manner by one observer (NY) without knowledge
of the clinical data. Periodic acid—Schiff (PAS)-stained sections
were used for the classification of mesangial changes.
Renal biopsies in which less than 50% of glomeruli showed
moderate or severe mesangial widening were excluded from the
analysis since the classification of mesangial changes was
difficult. The classification could usually be accomplished with-
out difficulty in biopsies showing moderate or severe mesangial
widening in more than 50% of glomeruli. It was difficult to
determine whether mesangial changes were types A or B in two
biopsies and types B or C in two biopsies. Electron microscopy
was used for the classification of these four biopsies. Eighty—
one patients were available for analysis.
The clinical and laboratory findings in the 81 patients were
obtained from the medical records after examination of the
biopsy specimen was completed. Hematuria was defined as an
erythrocyte excretion 10/mm3 of uncentrifuged urine or 5 per
high—power field of centrifuged urine. The acute nephritic
syndrome was defined as hematuria associated with hyperten-
sion and/or glomerular filtration rate (GFR) < 60 mllmin/1.73
m2. The nephrotic syndrome was defined as heavy proteinuria
and hypoalbuminemia 25 g/liter. Heavy proteinuria was de-
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fined as a urinary protein excretion 1.0 g/daylm2 body surface
area. Hypertension was diagnosed when the diastolic pressure
was persistently 90 mm Hg. GRF was determined by creati-
nine clearance, the lower limit of normal in our laboratory being
80 mi/mm/i .73 m2. Renal failure was defined as persistently
decreased GFR <60 mI/mm/i .73 m2.
Percutaneous renal biopsy was performed as previously
described [7]. Biopsy specimens for light microscopy were
stained with hematoxylin—eosin, PAS, and silver methenamine.
Tissue for immunofluorescence was stained with fluores-
cein—tagged commercial antisera to human IgG, IgA, 1gM, C4,
C3 and fibrinogen (Hoechst, Darmstadt, West Germany). Ul-
trathin sections were stained with uranyl acetate and lead
citrate, and examined with a JEM-100S electron microscope
(JEOL, Tokyo, Japan). One or two glomeruli from each spec-
imen were examined.
Statistical analyses were performed using the Student t-test
for comparison of means and the chi—square test for the
association of categorical variables. Results are given in the text
and tables as mean 1 st.
Results
Renal biopsy
Thirty—one patients had a repeat renal biopsy. Eleven pa-
tients showed transition of the mesangial change from one type
to another; seven from type A to type B, three from type A to
type C and one from type B to type C (Table 1). The two
biopsies from each of these 11 patients were included in the two
different types. Thus, 92 biopsies from 81 patients were avail-
able for analysis. There were 34 biopsies in type A, 36 in type
B and 22 in type C.
Light microscopy
The mean time of the biopsy from onset or discovery of
urinary abnormalities was significantly longer in type C than in
types A (P < 0.001) or B (P < 0.01), and was significantly
shorter in type A than in type B (P < 0.01) (Table 2). The most
constant abnormality was a widening of the glomerular mesan-
gium. Mesangial widening was produced by a variable combi-
nation of mesangial hypercellularity and increase in PAS-
positive mesangial matrix. Although the degree of mesangial
widening varied considerably among glomeruli as well as among
different mesangial regions of a single glomerulus, the type of
change was similar in the mesangia of the same biopsy speci-
men. In biopsy showing type C mesangial change, eosinophilic,
PAS-positive, homogeneous nodular deposits in the mesangium
were often observed. The percentage of glomeruli showing
global sclerosis was significantly higher in type C than in type A
(P < 0.05) and the percentage of glomeruli showing segmental
sclerosis was also significantly higher in type C than in types A
Fig. I . Tsp A in esangial c/in ill! . Mesa ngi a I hype i-cell Lii an iv is p re —
dominant compared with increase in niatri (PAN. X450)
Fig. 2. Tvpc H ,nexcit,gwl c/tangcv. The degrees of niesangial
hypercellular-ity and niainix increase are similar. (PAS. x450)
Fig. 3. Tv/ic C i?icSaIiguI/ c/wages. increase in main x is predominant
compared to mesangial cellularity. (MS. X4(II
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Table 1. Eleven patients with transition of mesangial change
Patient
no. Sex
Age at
onset
years Initial presentation
Biopsy
no.
Time of biopsy
from onset of
disease months
Mesangial
change
type
Follow—up
Duration
months
Clinical
status
I F 8 Asymptomatic P+H 1
2
36
71
A
C
89 P+H
2 F 12 Macroscopic H 1
2
3
9
A
C
46 Renal failure
3 F 6 Macroscopic H I
2
I
6
A
C
16 P+H
4 M II Macroscopic H 1
2
1
33
A
B
55 P+H
5
6
M
F
7
11
Nephritic and ne-
phrotic syndrome
Nephritic and ne-
phrotic syndrome
1
2
1
2
1
38
1
32
A
B
A
B
63
37
Normal
urine
Renal failure
7 F 10 Asymptomatic P+H 1
2
4
35
A
B
59 P+H
8 F 10 Asymptomatic P+H 1
2
4
40
A
B
47 P+H
9 F 10 Macroscopic H 1
2
12
46
A
B
70 Normal
urine
10 F 6 Asymptomatic P+H 1
2
2
6
A
B
15 P+H
11 M 7 Macroscopic H 1
2
5
43
B
C
46 P+H
Abbreviations are: P, proteinuria; H, hematuria.
Table 2. Light microscopy findings
Mesangial changes
Type
A B C
No. of biopsies
Time of the biopsy from
34
4.1 40a.b
36
19 21
22
38 27al
onset of disease
months
Global sclerosis 6 (18%) 8 (22%) 8 (36%)
Glomeruli showing 1.4 3.3% 4.0 8.7% 6.0 lO%c
global sclerosis
Segmental sclerosis 4 (12%) 5 (14%) 7 (32%)
Glomeruli showing 0.6 l.9%c 1.2 3.2%c 9.5 l8%
segmental sclerosis
Crescents 22 (65%) 18 (50%) 6 (27%)
Glomeruli showing 11 17%C 9.4 13% 4.0 8.7%c
crescents
Capsular adhesions 18 (53%) 19 (53%) 10 (45%)
Glomeruli showing 4.6 6.5% 9.1 13% 5.6 10%
adhesions
Tubulointerstitial 18 (53%) 22 (61%) 13 (59%)
changes
a < 0.01b P < 0.001
P < 0.05
or B (P < 0.05). In contrast, the percentage of glomeruli
showing crescent was significantly higher in type A than in type
C (P < 0.05). Focal tubular atrophy, together with interstitial
cellular infiltration and fibrosis, were frequently observed.
There were no vascular changes.
Serial pathologic observations were made in 31 patients
(Table 3). Eighteen patients showed type A and only three
showed type C in the first biopsy, while only one showed type
A and 13 showed type C in the second biopsy. Duration of
Table 3. Initial and foilow—up biopsy findings
Follow—up biopsy Mesangial
widening
Type Type Type < 50% of
Initial biopsy N A B C glomeruli
TypeA 18 1 7 3 7
TypeB 4 0 0 1 3
TypeC 3 0 0 3 0
Mesangial widening < 50% of
glomeruli 6 0 0 6 0
disease before the first biopsy in three patients showing type C
in the first biopsy was long (15, 51 and 63 months, respectively).
Immunofluorescence microscopy
The diagnostic immunopathologic pattern of IgA nephrop-
athy was diffuse deposits of IgA in the mesangial areas, often
extending into adjacent capillary walls. IgA deposition with a
lumpy pattern was often observed in type C. IgA deposits were
associated with IgG in 41% of the biopsies in type A, 31% in
type B and 45% in type C, and 1gM in 24% in type A, 19% in
type B and 23% in type C, although these were usually less
intense. C3 in a similar distribution pattern was observed in
76% of the biopsies in type A, 61% in type B and 68% in type C,
and C4 in 9% in type A and 8% in type B, though these were
usually less intense than IgA. Fibrinogen in a diffuse mesangial
and/or capillary distribution was noted in 44% of the biopsies in
type A, 44% in type B and 59% in type C.
Electron microscopy
Thirty—two biopsies in type A, 33 in type B and 20 in type C
were studied by electron microscopy. Electron—dense deposits
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Table 4. Initial clinical findings
Type
Mesangial changes A B C
No. of patients 24 35 22
Age at onset years 8.7 2.6 9.7 2.7 10.2 2.3
SexM/F 20/4a 18/17 9/13a
Initial presentation
Acute nephritic and ne- 3 3
phrotic syndrome
Nephrotic syndrome and 2 1
hematuria
Macroscopic hematuria 4 8 2
Asymptomatic proteinuria 15 (63%)" 23 (66%)" 20 (91%)"
and/or hematuria
ap <0.01
b P < 0.001
in the mesangium were the most constant and prominent feature
and were seen in 97% of the biopsies examined in type A, 88%
in type B and 100% in type C. They were granular masses
situated immediately beneath the lamina densa in the perime-
sangial region, and expanded the mesangium. The size and
extent of mesangial deposits varied from biopsy to biopsy, and
they were often so large as to produce localized protrusions in
type C. Peripheral glomerular capillary wall deposits were also
found in the subendothelial region in 59% of the biopsies
examined in type A, 42% in type B and 45% in type C, and in
the subepithelial region in 47% in type A, 42% in type B and
50% in type C. These deposits were usually small and scanty.
The subendothelial deposits occurred most frequently in the
capillary wall adjacent to the mesangium, although they were
also observed in the peripheral part of the loops. The subepi-
thelial deposits were often surrounded by replicated lamina
densa. Changes of the glomerular basement membrane such as
thinning and lamination of the lamina densa, and expansion of
the lamina rare externa were noted in 44% of the biopsies
examined in type A, 45% in type B and 20% in type C.
Clinical findings at presentation
The initial clinical findings are shown in Table 4. Eleven
patients showing transition of the mesangial change (Table 1)
were classified on the basis of the second biopsy findings. There
were 24 patients in type A, 35 in type B and 22 in type C. Age
at onset of disease was similar in the three types. Boys
predominated in type A but girls predominated in type B (P <
0.01). Six patients presented acute nephritic and nephrotic
syndrome and three nephrotic syndrome and hematuria. Four-
teen patients had macroscopic hematuria without nephritic or
nephrotic syndrome. Fifty—eight patients were found to have
microscopic and/or asymptomatic proteinuria by a school
screening program or routine medical examination. The per-
centage of patients who presented with asymptomatic protein-
uria and/or hematuria was significantly higher in type C than in
types A or B (P < 0.001). None of the patients who presented
with acute nephritic and/or nephrotic syndrome showed type C
mesangial change.
Table 5. Clinical status at latest follow—up
Mesangial changes
Type
A B C
No. of patients 24 35 22
Duration of follow—up
months 47 25 52 27 52 24
Normal urine 8 12 2 (9%)'
(58%) (57%)b
Hematuria only 6 8
Proteinuria with or
without hematuria 10 14 18
Renal failure 0 1 2
a < 0.01b P < 0.001
Follow—up
Twenty—two patients had normal urine, blood pressure and
GFR, and 14 had hematuria only when last seen. Forty—two
patients had persistent proteinuria with or without hematuria.
In three patients renal failure developed. One had a surviving
renal transplant and one was receiving regular hemodialysis.
The duration of follow—up was similar in the three types.
Fourteen patients (58%) showing type A and 20 (57%) showing
type B lost their proteinuria, whereas only two (9%) showing
type C lost their proteinuria (P < 0.01).
Discussion
The diagnostic features of IgA nephropathy are diffuse me-
sangial deposits of IgA, frequently accompanied by C3 and
sometimes by IgG and 1gM. Mesangial deposits of IgA are also
seen in systemic diseases such as Henoch—SchOnlein purpura
[8] and systemic lupus erythematosus [9]. However, recent
studies [10—12] have provided both clinical and histopathologic
evidence that IgA nephropathy should be considered a distinct
clinico-pathologic entity. In spite of diverse clinical features,
the morphological findings were similar in all children with IgA
nephropathy. The most uniform abnormality is a global or
segmental widening of the glomerular mesangium due to a
variable combination of hypercellularity and increase in matrix.
A number of studies have attempted to correlate the degree of
mesangial proliferation with clinical findings and the subsequent
course of disease, but little attention has been paid to the
significance of mesangial hypercellularity and increase in ma-
trix.
We observed predominant mesangial hypercellularity com-
pared to matrix increase in 34 of the 92 biopsies. These biopsies
showed a short interval between onset of disease and biopsy,
and a high percentage of crescent formation. Serial pathologic
observations revealed that prominent mesangial hypercellular-
ity was almost exclusively seen in the initial biopsy and
disappeared in the follow—up biopsy. These observations sug-
gest that predominant mesangial hypercellularity is character-
istic of the early lesion of childhood IgA nephropathy and may
disappear within a matter of months. We have not seen pre-
dominant mesangial hypercellularity in previous reports. Zim-
merman and Burkholder [91 reported that an increase in mesan-
gial cells, though sometimes present, was seldom very striking
in adult patients. The failure of previous studies to recognize
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this predominant mesangial hypercellularity may be due in part
to the difference between adults and children; the majority of
patients in previous reports were adults. More likely, however,
is the short interval between onset of disease and renal biopsy
in our study. An asymptomatic period preceding the apparent
onset of IgA nephropathy may be very long in adult patients.
Since the start of a school screening program for the detection
of urinary abnormalities in 1974, all Japanese children have
been screened every year. Thus, the majority of patients with
IgA nephropathy in our study were diagnosed early in the
course of the disease, and the asymptomatic period before the
discovery of urinary abnormalities did not exceed several
months.
In contrast to mesangial hypercellularity, biopsies with pre-
dominant matrix increase showed a long interval between onset
of disease and biopsy, and a high percentage of sclerosis. Serial
pathologic observations revealed that prominent matrix in-
crease was usually seen in the follow—up biopsy. Although three
patients showed prominent matrix increase in the first biopsy,
the duration of disease before the first biopsy was 15, 51 and 63
months, respectively. Increasing mesangial matrix with dura-
tion of the disease has also been noted in adult patients by
Clarkson et al [13] and Hara et a! [14]. This study suggests that
predominant matrix increase is characteristic of the late lesion,
and progression of IgA nepropathy leads to gradual decrease of
mesangial cellularity and increase of matrix associated with
sclerosis.
IgA nephropathy was initially considered a benign disease.
As data from long—term follow—up studies became available,
progression of the disease to renal failure in 20 to 50% of adult
patients was recognized [12]. In children, a more benign prog-
nosis has been indicated [15—17]. However, only 27% of our
patients were in clinical remission when last seen. Clarkson et
a! [13] and Croker, Dawson and Sanfilippo [18] have proposed
a concept that IgA nephropathy is an indolent, chronic disease
that may begin in childhood and may slowly progress to chronic
renal failure. Berger [19] pointed out that a number of patients
who have developed end—stage renal disease in early adult life
developed their initial clinical features during childhood. We
suspect, therefore, that a significant proportion of children with
IgA nephropathy may develop renal failure. Long—term follow—
up studies are necessary to confirm this thesis.
In recent studies of repeat renal biopsies, Berthoux et al [20]
and Levy et a! [17] reported the importance of the first renal
biopsy regarding the clinical outcome of IgA nephropathy and
suggested that the histologic grading of an early renal biopsy
was a reliable prognostic indicator. Follow—up biopsy findings
in this study indicate that repeat renal biopsy is important in
children with IgA nephropathy, particularly with persistent
proteinuria, as a progression of glomerular changes is common
in these patients.
Patients with predominant matrix increase were resistant to
treatment, had persistent proteinuria at follow—up and did not
show decrease of matrix in repeat biopsy. As predominant
matrix increase is an irreversible glomerular change and pro-
duces glomerular sclerosis, a prophylactic approach to the
problem of IgA nephropathy, based on an arbitrary period of
therapy early in the course of children with IgA nephropathy,
warrants serious consideration and investigation.
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